(Q39619019)

English

Expression of gangliosides, GD1a, and sialyl paragloboside is regulated by NF-κB-dependent transcriptional control of α2,3-sialyltransferase I, II, and VI in human castration-resistant prostate cancer cells

scientific article published on 13 April 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Expression of gangliosides, GD1a, and sialyl paragloboside is regulated by NF-κB-dependent transcriptional control of α2,3-sialyltransferase I, II, and VI in human castration-resistant prostate cancer cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Koji Hatano

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Yasuhide Miyamoto

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Norio Nonomura

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Yasufumi Kaneda

4

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

language of work or name

0 references

publication date

13 April 2011

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

129

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

1838-1847

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

The biology of hormone refractory prostate cancer. Why does it develop?

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

Prostate cancer gene therapy clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

Docetaxel increases antitumor efficacy of oncolytic prostate-restricted replicative adenovirus by enhancing cell killing and virus distribution

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

Oncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances antitumor efficacy in prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

Efficient eradication of hormone-resistant human prostate cancers by inactivated Sendai virus particle

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

Inactivated Sendai virus particles eradicate tumors by inducing immune responses through blocking regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

Role of sialic acid-containing molecules in paramyxovirus entry into the host cell: a minireview

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

Gangliosides of organ-confined versus metastatic androgen-receptor-negative prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

Endogenous immune response to gangliosides in patients with confined prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

A vital role for glycosphingolipid synthesis during development and differentiation

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

Enhancement of epidermal growth factor signaling and activation of SRC kinase by gangliosides

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

Exogenous ganglioside GD1a enhances epidermal growth factor receptor binding and dimerization

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

Glycosphingolipid composition of primary cultured human brain microvascular endothelial cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

Characterization of mouse sialyltransferase genes: their evolution and diversity

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

Kinetic properties and acceptor substrate preferences of two kinds of Gal beta 1,3GalNAc alpha 2,3-sialyltransferase from mouse brain

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

Mouse beta-galactoside alpha 2,3-sialyltransferases: comparison of in vitro substrate specificities and tissue specific expression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

Molecular cloning of a novel alpha2,3-sialyltransferase (ST3Gal VI) that sialylates type II lactosamine structures on glycoproteins and glycolipids

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

Human α2,3-Sialyltransferase (ST3Gal II) Is a Stage-specific Embryonic Antigen-4 Synthase

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

STAT-1 and AP-1 decoy oligonucleotide therapy delays acute rejection and prolongs cardiac allograft survival.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

The role of extracellular matrix metalloproteinase inducer protein in prostate cancer progression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

NF-kappaB activation in human prostate cancer: important mediator or epiphenomenon?

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

Nuclear localisation of nuclear factor-kappaB transcription factors in prostate cancer: an immunohistochemical study

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growth.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

Molecular cloning and functional analysis of sialyltransferases

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

IKK/NF-kappaB and STAT3 pathways: central signalling hubs in inflammation-mediated tumour promotion and metastasis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

Genomic structure and transcriptional regulation of human Galbeta1,3GalNAc alpha2,3-sialyltransferase (hST3Gal I) gene

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

Genomic structure, expression, and transcriptional regulation of human Gal beta 1,3 GalNAc alpha 2,3-sialyltransferase gene

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

Gene structure and transcriptional regulation of human Gal beta1,4(3) GlcNAc alpha2,3-sialyltransferase VI (hST3Gal VI) gene in prostate cancer cell line

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

NFkappaB-p65 dependent transcriptional regulation of glycosyltransferases in human colon adenocarcinoma HT-29 by stimulation with tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

NF-kappaB p52:RelB heterodimer recognizes two classes of kappaB sites with two distinct modes

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

PTEN-mediated pathways and their association with treatment-resistant prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

Mechanisms of prostate cancer cell survival after inhibition of AR expression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

Phosphoinositide 3-kinase pathway activation in phosphate and tensin homolog (PTEN)-deficient prostate cancer cells is independent of receptor tyrosine kinases and mediated by the p110beta and p110delta catalytic subunits

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

RelB enhances prostate cancer growth: implications for the role of the nuclear factor-kappaB alternative pathway in tumorigenicity

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

Activator Protein-1 Transcription Factors Are Associated with Progression and Recurrence of Prostate Cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25860

21 January 2018

Identifiers

10.1002/IJC.25860

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39619019&oldid=1846104391"